Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **dynein light chain Tctex-type 1 pseudogene** is a nonfunctional DNA sequence in the human genome, resembling the functional DYNLT1 gene but incapable of producing a functional protein product[5][6]. Pseudogenes like this typically arise through gene duplication or retrotransposition followed by accumulation of disabling mutations (e.g., frameshifts, premature stop codons)[2][6]. Most pseudogenes have no biological role, but a minority may produce noncoding RNAs that participate in the complex regulation of gene expression, including ceRNA (competing endogenous RNA) networks[4][6]. ENSG00000250613 is not a drug target and should not be confused with the functional DYNLT1 gene, which is an accessory component of the cytoplasmic dynein motor protein complex[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dynein light chain Tctex-type 1 pseudogene.